Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $4.68B.
ENTERPRISE VALUE (EV)
$4.68B
Dianthus Therapeutics, Inc.
Market Cap
$4.73B
Enterprise Value (EV)
$4.68B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Dianthus Therapeutics, Inc. (DNTH) | $4.73B | $4.68B |
| BillionToOne, Inc. (BLLN)vs › | $4.69B | $4.28B |
| LifeStance Health Group, Inc. (LFST)vs › | $4.64B | $4.61B |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.83B | $5.26B |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.61B | $3.99B |
| Erasca, Inc. (ERAS)vs › | $4.89B | $4.89B |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.45B | $4.69B |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.06B | $4.83B |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.38B | $4.37B |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.38B | $4.67B |
Market Cap
$4.73B
Total Debt
$1.02M
Cash
$51.09M
Enterprise Value
$4.68B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
